Pharmacophoric pattern of anti-epileptic sulfonamides and sulfamates. Theoretical study of the associated requirements
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2002
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 07347caa a22011177a 4500 | ||
|---|---|---|---|
| 001 | PAPER-5403 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203503.0 | ||
| 008 | 190411s2002 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0037192715 | |
| 024 | 7 | |2 cas |a acetazolamide, 1424-27-7, 59-66-5; carbamazepine, 298-46-4, 8047-84-5; carbonate dehydratase, 9001-03-0; phenytoin, 57-41-0, 630-93-3; topiramate, 97240-79-4 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a THEOD | ||
| 100 | 1 | |a Barrios, I.A | |
| 245 | 1 | 0 | |a Pharmacophoric pattern of anti-epileptic sulfonamides and sulfamates. Theoretical study of the associated requirements |
| 260 | |b Elsevier |c 2002 | ||
| 270 | 1 | 0 | |m Estiú, G.L.; Departamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Casilla de Correo 962, 1900 La Plata, Argentina; email: estiu@biol.unlp.edu.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Rogawski, M.A., Porter, R.J., (1990) Pharmacol. Rev., 42, pp. 223-285 | ||
| 504 | |a Löscher, W., Schmidt, D., (1994) Epilep. Res., 17, pp. 95-134 | ||
| 504 | |a Patsalos, P.N., Duncan, J.S., (1994) CNS Drugs, 2, pp. 40-70 | ||
| 504 | |a Britton, J.W., So, E.L., (1995) J. Epilep., 8, pp. 267-281 | ||
| 504 | |a Fisher, R., Blum, D., (1995) Epilepsia, 36 (S2), pp. S105-S114 | ||
| 504 | |a Dichte, M.A., Brodie, M.J., Engla, N., (1996) J. Med., 334, pp. 1583-1590 | ||
| 504 | |a Levy, R.H., Mattson, R.H., Meldrum, B.S., (1995) Antiepilptic Drug 4th ed., , Raven Press, New York | ||
| 504 | |a Benetello, P., (1995) Pharmacol. Res., 31, pp. 155-162 | ||
| 504 | |a Trimble, M.R., (1994) New Anticonvulsants Advances in the Treatment of Epilepsy, , Wiley, New York | ||
| 504 | |a Marson, A.G., Kadir, Z.A., Chadwick, D.W., (1996) Br. Med. J., 313 (7066), pp. 1169-1174 | ||
| 504 | |a Brodi, M.J., (1990) Lancet, 336, pp. 93-96 | ||
| 504 | |a Lindhout, D., Omtzigt, J.G.C., (1994) Epilepsia, 35 (SUPPL. 4), pp. S19-S28 | ||
| 504 | |a Jallon, P., (1997) Epilepsia, 38, pp. S37-S42 | ||
| 504 | |a Bazil, C.W., Pedley, T.A., (1998) Ann. Rev. Med., 49, p. 135 | ||
| 504 | |a Maryanoff, B.E., Costanzo, M.J., Nortey, S.O., Greco, M.N., Shank, R.P., Schupsky, J.J., Ortegon, M.P., Vaught, J.L., (1998) J. Med. Chem., 41, pp. 1315-1343 | ||
| 504 | |a Tasso, S.M., Bruno-Blanch, L.E., Moon, S.C., Estiú, G.L., (2000) J. Mol. Struct. (Theochem), 504, pp. 229-240 | ||
| 504 | |a Chufán, E.E., Pedregosa, J.C., Baldini, O.N., Bruno-Blanch, L.E., (1999) Il Farmaco, 54, pp. 838-841 | ||
| 504 | |a Wolff, M.E., (1996) Burger's Medical Chemistry and Drug Discovery, Anticonvulsant, 3. , Wiley, New York, chapter 39 | ||
| 504 | |a Shek, E., Murakami, T., Nath, C., Pop, E., Bodor, N.S., (1989) J. Pharm. Sci., 78, p. 10 | ||
| 504 | |a Ho, B., Venkatarangan, P.M., Cruse, S.F., Hinko, C.N., Andersen, P.H., Crider, A.M., Adloo, A.A., Stables, J.P., (1998) Eur. J. Med. Chem., 33, pp. 23-31 | ||
| 504 | |a Taylor, C., (1999) Adv. Neurol., 79, pp. 1011-1026 | ||
| 504 | |a Stewart, J.J.P., (1994) MOPAC, Version 7.0, , F.J. Seiler Research Laboratory, United State Air Force Academy, CO 80840, USA | ||
| 504 | |a Frisch, M.J., Trucks, G.W., Schleldel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Pople, J.A., (1998) GAUSSIAN 98, Revision A.9, , Gaussian, Inc., Pittsburgh PA | ||
| 504 | |a Zimanyi, I., Weiss, S.R.B., Laajtha, A., (1989) Eur. J. Pharmacol., 167, pp. 419-442 | ||
| 504 | |a Koike, T., Kimura, E., Nakamura, I., Hashimoto, Y., Shiro, M., (1992) J. Am. Chem. Soc., 114, pp. 7338-7345 | ||
| 504 | |a Erikson, A.E., Kylsten, P.M., Jones, T.A., Liljas, A., (1988) Proteins, p. 283 | ||
| 536 | |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica, 06-03237, 98 | ||
| 536 | |a Detalles de la financiación: Universidad Nacional de La Plata | ||
| 536 | |a Detalles de la financiación: G.L. Estiú is a member of the Consejo Nacional de Investigaciones Cientı́ficas y Técnicas de la República Argentina (CONICET), and L.E. Bruno-Blanch of the Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Argentina. I.A. Barrios is a fellowship holder of Agencia Nacional de Ciencia y Tecnologı́a Pict 98 No 06-03237. This work has been supported in part through grants from Universidad Nacional de La Plata, Agencia Nacional de Ciencia y Tecnologı́a Pict 98 No 06-03237 and Laboratorios Bagó, Argentina. | ||
| 593 | |a Química Medicinal, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de la Plata, CC 243, 1900 La Plata, Argentina | ||
| 593 | |a CEQUINOR, Departamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Nacional de la Plata, Casilla de Correo 962, 1900 La Plata, Argentina | ||
| 593 | |a DQIAyFQ. Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a CEQUINOR, Departamento de Ciencias Que., Facultad de Ciencias Exactas, Universidad Nacional de la Plata, Casilla de Correo 962, 1900 La Plata, Argentina | ||
| 690 | 1 | 0 | |a ANTI-CONVULSANT ACTIVITY |
| 690 | 1 | 0 | |a PHARMACOPHORIC PATTERN |
| 690 | 1 | 0 | |a SODIUM CHANNEL |
| 690 | 1 | 0 | |a SULFAMOYL DERIVATIVES |
| 690 | 1 | 0 | |a 2 PROPYLPENTYL SULFAMATE |
| 690 | 1 | 0 | |a 5 AMINO 1,3,4 THIADIAZOLE 2 SULFONAMIDE |
| 690 | 1 | 0 | |a 5 TERT BUTOXYCARBONYLAMIDO 1,3,4 THIADIAZOLE 2 SULFONAMIDE |
| 690 | 1 | 0 | |a ACETAZOLAMIDE |
| 690 | 1 | 0 | |a ANTICONVULSIVE AGENT |
| 690 | 1 | 0 | |a CARBAMAZEPINE |
| 690 | 1 | 0 | |a CARBONATE DEHYDRATASE |
| 690 | 1 | 0 | |a N BUTYL 2 PROPYLPENTYL SULFAMATE |
| 690 | 1 | 0 | |a N CYCLOPROPYL 2,3 ISOPROPYLIDENE 4,5 SULFONYL BETA DEXTRO FRUCTOPYRANOSE SULFAMATE |
| 690 | 1 | 0 | |a N METHYL 2,3 ISOPROPYLIDENE 4,5 SULFONYL BETA DEXTRO FRUCTOPYRANOSE SULFAMATE |
| 690 | 1 | 0 | |a N MORPHOLINE 2 PROPYLPENTYL SULFAMATE |
| 690 | 1 | 0 | |a PHENYTOIN |
| 690 | 1 | 0 | |a RWJ 37947 |
| 690 | 1 | 0 | |a SULFONAMIDE |
| 690 | 1 | 0 | |a TOPIRAMATE |
| 690 | 1 | 0 | |a UNCLASSIFIED DRUG |
| 690 | 1 | 0 | |a ANTICONVULSANT ACTIVITY |
| 690 | 1 | 0 | |a CALCULATION |
| 690 | 1 | 0 | |a CONFERENCE PAPER |
| 690 | 1 | 0 | |a DRUG CONFORMATION |
| 690 | 1 | 0 | |a DRUG MECHANISM |
| 690 | 1 | 0 | |a DRUG STRUCTURE |
| 690 | 1 | 0 | |a DRUG SYNTHESIS |
| 690 | 1 | 0 | |a ELECTRIC SHOCK |
| 690 | 1 | 0 | |a ENZYME INHIBITION |
| 690 | 1 | 0 | |a PHARMACOPHORE |
| 690 | 1 | 0 | |a QUANTUM CHEMISTRY |
| 690 | 1 | 0 | |a STRUCTURE ANALYSIS |
| 690 | 1 | 0 | |a THEORETICAL STUDY |
| 653 | 0 | 0 | |a rwj 37947 |
| 700 | 1 | |a Bruno-Blanch, L.E | |
| 700 | 1 | |a Estiú, G.L | |
| 773 | 0 | |d Elsevier, 2002 |g v. 580 |h pp. 243-250 |k n. 1-3 |p J. Mol. Struct. THEOCHEM |x 01661280 |w (AR-BaUEN)CENRE-1043 |t Journal of Molecular Structure: THEOCHEM | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037192715&doi=10.1016%2fS0166-1280%2801%2900620-0&partnerID=40&md5=90b5336a456724df4f00b5a37392c8dd |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0166-1280(01)00620-0 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_01661280_v580_n1-3_p243_Barrios |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01661280_v580_n1-3_p243_Barrios |y Registro en la Biblioteca Digital |
| 961 | |a paper_01661280_v580_n1-3_p243_Barrios |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 963 | |a VARI | ||
| 999 | |c 66356 | ||